Explore Baker Brothers' biotech-focused 13F portfolio, with notable stake increases in Incyte, Summit Therapeutics, and other ...

We recently published a list of 10 Worst ARK Stocks To Buy According to Short Sellers. In this article, we are going to take ...

In a report released today, Joseph Catanzaro from Piper Sandler maintained a Buy rating on Nurix Therapeutics (NRIX – Research Report), with a ...

Analyst Robert Burns from H.C. Wainwright reiterated a Buy rating on Nurix Therapeutics (NRIX – Research Report) and increased the price target ...

Fintel reports that on December 10, 2024, BTIG initiated coverage of Nurix Therapeutics (NasdaqGM:NRIX) with a Buy ...

For our list of the worst Ark stocks to buy according to short sellers, we ranked the 110 largest holdings in Ark Invest’s Q3 ...

SAN DIEGO -- A fixed-duration oral combination significantly reduced the risk of disease progression or death compared with ...

BMO Capital Markets started coverage on shares of Nurix Therapeutics (NASDAQ:NRIX – Free Report) in a report released on ...

During the last three months, 9 analysts shared their evaluations of Nurix Therapeutics NRIX, revealing diverse outlooks from ...

Fintel reports that on December 6, 2024, BMO Capital initiated coverage of Nurix Therapeutics (NasdaqGM:NRIX) with a ...